Pro Medicus Limited (ASX: PME)
Market Cap | 25.98B |
Revenue (ttm) | 161.50M |
Net Income (ttm) | 82.79M |
Shares Out | 104.50M |
EPS (ttm) | 0.79 |
PE Ratio | 313.83 |
Forward PE | 235.66 |
Dividend | 0.44 (0.18%) |
Ex-Dividend Date | Sep 4, 2024 |
Volume | 567,577 |
Open | 250.23 |
Previous Close | 250.23 |
Day's Range | 246.53 - 252.00 |
52-Week Range | 85.60 - 271.37 |
Beta | 0.56 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Feb 12, 2025 |
About Pro Medicus
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and commu... [Read more]
Financial Performance
In 2024, Pro Medicus's revenue was 161.50 million, an increase of 29.30% compared to the previous year's 124.90 million. Earnings were 82.79 million, an increase of 36.52%.
Financial StatementsNews
Pro Medicus billionaires in $500m sell-down
The trade crossed the screen in two lines on Tuesday afternoon, with about 2 million shares changing hands at last price.
Rocket stock Pro Medicus redefines what’s possible
The medical software company is the sort of investment that makes you glad your job does not decide on picking whether it is a market winner or loser.
Earnings-season surprises shake up ASX short sellers
Fortescue, Woodside Energy and Pro Medicus have topped the list of companies being bet against as hedge funds rework their strategies after reporting season.
Why tech bolters are lighting up reporting season
WiseTech, Pro Medicus, Life 360 and REA Group have turned heads this season as tech proves the sweet spot for growth investors again.
Pro Medicus Limited (PMCUF) Q4 2024 Earnings Call Transcript
Pro Medicus GAAP EPS of A$0.79, revenue of A$166.33M
Pro Medicus share surge defies growth warning
Shares in market darling Pro Medicus jumped on the company’s latest bumper profit, but its CEO says that level of growth will be hard to maintain.
The five best-performing ASX 200 stocks this financial year
Healthcare software developer Pro Medicus narrowly bested family monitoring app Life360 to be the top-performing stock, with a 118.7 per cent return in 12 months.
The ASX business so good ‘you can’t put a sell on it’
Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.
Why Paradice is backing Seven Group’s bid for Boral
Mid cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.
ASX PME:
A $2.8 million share buyback helped restore $1.2 billion of value to Pro Medicus, and bulls think the stock – which is already trading at a sky-high multiple – has further to run.
Pro Medicus reports 1H results
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
The Aussies hoping to make a fortune from Apple’s Vision Pro
The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.
Pro Medicus founders in $176m selldown; Unified Capital nabs trade
Fund managers sources said Anthony Hall and Sam Hupert had stockbroker Unified Capital Partners seeking buyers for 2 million shares at $88 apiece.
Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q2 2023 Earnings Conference Call February 14, 2023 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Confer...
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2022 Results - Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q4 2022 Earnings Conference Call August 17, 2022 9:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fina...
Pro Medicus Limited (PMCUF) CEO Sam Hupert On Q2 2022 Results - Earnings Call Transcript
ro Medicus Limited (OTCPK:PMCUF) Q2 2022 Earnings Conference Call February 15, 2022 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fin...
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2020 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2020 Results - Earnings Call Transcript
Pro Medicus: Healthcare IT Developer With Impressive Growth Story
Pro Medicus: Healthcare IT Developer With Impressive Growth Story
Pro Medicus: An Emerging Star In Digital Healthcare
Pro Medicus has been an exceptionally strong performer for my high growth, Project $1M portfolio, returning more than 250% over the last 3 years .